Application 209304
- Type
- ANDA
- Sponsor
- TELIGENT PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GENTAMICIN SULFATE | GENTAMICIN SULFATE | CREAM;TOPICAL | EQ 0.1% BASE | No | No |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A209304-001 | GENTAMICIN SULFATE | EQ 0.1% BASE | CREAM / TOPICAL | AT | 2019-10-18 | 74a2ff9319b5… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209304-001 | GENTAMICIN SULFATE | EQ 0.1% BASE | CREAM / TOPICAL | AT | 2019-10-18 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A209304-001 | GENTAMICIN SULFATE | EQ 0.1% BASE | CREAM / TOPICAL | AT | 2019-10-18 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A209304-001 | GENTAMICIN SULFATE | EQ 0.1% BASE | CREAM / TOPICAL | AT | 2019-10-18 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A209304-001 | GENTAMICIN SULFATE | EQ 0.1% BASE | CREAM / TOPICAL | AT | 2019-10-18 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A209304-001 | GENTAMICIN SULFATE | EQ 0.1% BASE | CREAM / TOPICAL | AT | 2019-10-18 | 3f01610625f2… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A209304-001 | AT | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209304-001 | AT | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A209304-001 | AT | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A209304-001 | AT | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A209304-001 | AT | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A209304-001 | AT | 1 | 3f01610625f2… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Hospira, Inc. | 977180b3-a222-4282-d485-4a3217674305 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cardinal Health 107, LLC | 5113bfad-42ca-4bb8-9343-0b08c6cd03f0 | 2026-05-08 | Boxed warning, Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Preferred Pharmaceuticals Inc. | 5ac8ea7a-ee89-49f5-8d30-6dbb56503d94 | 2026-05-05 | Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin | GENTAMICIN SULFATE | Henry Schein, Inc | 84f6eb1c-a287-489a-8c3e-aa5954cf1992 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Henry Schein, Inc. | 913a36c3-50d6-429a-a8dd-a03126d2ca08 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 3532bb39-a1a6-9d67-e063-6294a90abc0c | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 5193ed8d-44c9-46fe-924d-93aaea922cfd | 2025-05-01 | Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 0bef2a01-69d0-cf50-e063-6294a90a4c52 | 2025-02-03 | Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 84f5c763-1cd3-4d85-9afb-934db8666fbf | 2024-10-11 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals, Inc. | 4add8f7b-48f0-6b6a-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Bausch & Lomb Incorporated | 41d01350-5c4b-42fc-be5f-986ceec02bd3 | 2024-07-22 | Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 82595309-304e-a221-e053-2991aa0ac0a9 | 2024-06-14 | Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 85424b40-5c2d-421d-e053-2991aa0a7771 | 2024-06-14 | Warnings, Adverse reactions | GENTAMICIN SULFATE GENTAMICIN SULFATE |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | HF Acquisition Co LLC, DBA HealthFirst | e9fbe619-2afe-f1d7-e053-2a95a90aab29 | 2024-01-27 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | a9486ae1-350b-41c5-ae0c-a4d692bb2dfd | 2024-01-15 | Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| gentamicin sulfate | GENTAMICIN SULFATE | DIRECT RX | 51a411a0-2671-4c1c-bf25-e29b32efed0c | 2024-01-10 | Warnings, Adverse reactions | gentamicin sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Sandoz Inc | a213fb9c-08ea-4f30-a6c9-93c7a9ba5280 | 2024-01-02 | Warnings, Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 16474069-510b-0754-9d78-9bc0354f6549 | 2023-11-23 | Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 9e550dc9-509e-da05-8a97-ecbd0f5dd633 | 2023-11-22 | Adverse reactions | Gentamicin Sulfate GENTAMICIN SULFATE |
| Gentamicin | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 09cf88af-59da-f147-e063-6294a90aac99 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 52565-085 | Gentamicin Sulfate | gentamicin sulfate | Teligent Pharma, Inc. | ANDA | Current |
| 63739-055 | Gentamicin Sulfate Cream USP, 0.1% | Gentamicin Sulfate | McKesson Corporation | ANDA | Current |
| 70512-036 | Gentamicin Sulfate Cream 0.1% | Gentamicin Sulfate Cream 0.1% | Sola Pharmaceuticals | ANDA | Current |